Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP

Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP

Regulatory T cells play an important role in the progression of atherosclerosis. GARP is a newly biological membrane molecule existed on activated Tregs, which is related to the release of TGF-β. The antiatherosclerosis effects of statins partly depend on their multiple immune modulatory potencies....

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoqi Zhao, Yuzhou Liu, Yucheng Zhong, Bo Liu, Kunwu Yu, Huairui Shi, Ruirui Zhu, Kai Meng, Wei Zhang, Bangwei Wu, Qiutang Zeng
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2015/841472
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MicroRNA-208a Dysregulates Apoptosis Genes Expression and Promotes Cardiomyocyte Apoptosis during Ischemia and Its Silencing Improves Cardiac Function after Myocardial Infarction
by: Hasahya Tony, et al.
Published: (2015-01-01)

Mühimme Defterlerine Göre Osmanlı Cezayir-i Garp
by: H. Mustafa Eravcı
Published: (2017-06-01)

Ancient Piracy Activities of Garp Ocakları in Mediterranean World as an International Problem in XVIII Century
by: Serhat KUZUCU
Published: (2015-12-01)

Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
by: Murat Kiyici, et al.
Published: (2003-01-01)

Garp Linyitleri İşletmesi (GLİ) Şlam Kömürlerinin Spiral ile Zenginleştirilebilirliğine Tane Boyutunun Etkisi
by: Ali Uçar, et al.
Published: (2021-06-01)

15-Lipoxygenase-1 Is Involved in the Effects of Atorvastatin on Endothelial Dysfunction
by: Peng Zhang, et al.
Published: (2016-01-01)

T Lymphocyte Autoreactivity in Inflammatory Mechanisms Regulating Atherosclerosis
by: Elisabetta Profumo, et al.
Published: (2012-01-01)

Physicochemical Characteristics of Chitosan–Alginate Scaffold Containing Atorvastatin
by: Hananeh Hamedfar, et al.
Published: (2023-01-01)

Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism
by: N. D. B. Ehelepola, et al.
Published: (2017-01-01)

Phenolic-Rich Baccaurea angulata Modulates Inflammatory Biomarkers of Atherosclerosis
by: Muhammad Ibrahim, et al.
Published: (2018-01-01)

Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment
by: Joon‐Tae Kim, et al.
Published: (2025-02-01)

Autoantibodies Targeting AT1 Receptor from Patients with Acute Coronary Syndrome Upregulate Proinflammatory Cytokines Expression in Endothelial Cells Involving NF-κB Pathway
by: Weijuan Li, et al.
Published: (2014-01-01)

Direct Comparison of 19F qNMR and 1H qNMR by Characterizing Atorvastatin Calcium Content
by: Yang Liu, et al.
Published: (2016-01-01)

Peroxisome Proliferator-Activated Receptors in the Modulation of the Immune/Inflammatory Response in Atherosclerosis
by: Ana Z. Fernandez
Published: (2008-01-01)

Diverse Roles of Macrophages in Atherosclerosis: From Inflammatory Biology to Biomarker Discovery
by: Ting Gui, et al.
Published: (2012-01-01)

Towards the Application of Atorvastatin to Intensify Proapoptotic Potential of Conventional Antileukemic Agents In Vitro
by: Jolanta D. Żołnierczyk, et al.
Published: (2015-01-01)

Inhibition of miR-652-3p Regulates Lipid Metabolism and Inflammatory Cytokine Secretion of Macrophages to Alleviate Atherosclerosis by Improving TP53 Expression
by: Haiyun Liu, et al.
Published: (2022-01-01)

Dual-mode-driven nanomotors targeting inflammatory macrophages for the MRI and synergistic treatment of atherosclerosis
by: Min Wei, et al.
Published: (2025-01-01)

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Ramipril, Aspirin and Atorvastatin in Pharmaceutical Preparations
by: Rajesh Sharma, et al.
Published: (2012-01-01)

Simultaneous Detemination of Atorvastatin Calcium and Amlodipine Besylate by Spectrophotometry and Multivariate Calibration Methods in Pharmaceutical Formulations
by: Amir H. M. Sarrafi, et al.
Published: (2011-01-01)

Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature
by: Dimitrios Patoulias, et al.
Published: (2017-01-01)

Electrochemical sensing platform based on Ag-Fe metal–organic framework for electrocatalytic determination of Atorvastatin
by: Fatemeh Naji Siyahmazgi, et al.
Published: (2025-01-01)

Endothelial cells under disturbed flow release extracellular vesicles to promote inflammatory polarization of macrophages and accelerate atherosclerosis
by: Zhe Hou, et al.
Published: (2025-01-01)

Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
by: Fufangyu Zhao, et al.
Published: (2025-02-01)

LIF Upregulates Expression of NK-1R in NHBE Cells
by: Cheng-Ping Hu, et al.
Published: (2006-01-01)

Reaction of the Liver upon Long-Term Treatment of Fluoxetine and Atorvastatin Compared with Alcohol in a Mouse Model
by: Zhiliang Chen, et al.
Published: (2021-01-01)

Smad2/3 Upregulates the Expression of Vimentin and Affects Its Distribution in DBP-Exposed Sertoli Cells
by: Xi Zhang, et al.
Published: (2015-01-01)

Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression
by: Jie Qi, et al.
Published: (2020-01-01)

The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis
by: Zixia Huang, et al.
Published: (2022-01-01)

Decreased Regulatory T Cells in Vulnerable Atherosclerotic Lesions: Imbalance between Pro- and Anti-Inflammatory Cells in Atherosclerosis
by: Ilonka Rohm, et al.
Published: (2015-01-01)

The Relationship between Carotid Atherosclerosis, Inflammatory Cytokines, and Oxidative Stress in Middle-Aged and Elderly Hemodialysis Patients
by: Hongqi Ren, et al.
Published: (2013-01-01)

The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies
by: Fabrizio Montecucco, et al.
Published: (2009-01-01)

The Chylomicron: Relationship to Atherosclerosis
by: Gerald H. Tomkin, et al.
Published: (2012-01-01)

The Impact of Atorvastatin on Intraprostatic Biomarkers – Prognostic Value of 3LS-score – Follow-up of ESTO1-Trial
by: Eemil Lehtonen, et al.
Published: (2025-03-01)

Mini meta-analysis of anticholinesterase actions of atorvastatin, simvastatin and rosuvastatin, and in silico identification of their protein targets in Mus musculus
by: Fouad Kasim Mohammad, et al.
Published: (2025-06-01)

Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin
by: Hamad Abdulsalam Hamad Alfarisi, et al.
Published: (2020-01-01)

An Unexpected Interaction between Sofosbuvir/Ledipasvir and Atorvastatin and Colchicine Causing Rhabdomyolysis in a Patient with Impaired Renal Function
by: Shyam Patel, et al.
Published: (2016-01-01)

Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets
by: Hassan Said A., et al.
Published: (2016-12-01)

Galectin-3 Is a Potential Mediator for Atherosclerosis
by: Ziyu Gao, et al.
Published: (2020-01-01)

Protective Effects of Polydatin on Septic Lung Injury in Mice via Upregulation of HO-1
by: Xiao-hui Li, et al.
Published: (2013-01-01)